Danaher to buy Masimo in $9.9 billion deal in diagnostics push
Feb 17 (Reuters) - Danaher will acquire pulse oximeter maker Masimo in a $9.9 billion deal, as the life science firm looks to bulk up its diagnostics portfolio.
The companies said on Tuesday that Danaher will pay $180 per share to buy Masimo. The offer... Read More.


